Article
In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients.
The new microbiologica - 1 Oct 2005
Gianotti Nicola, Galli Laura, Boeri Enzo, Maillard Myriam, Serra Giuseppe, Ratti Deborah, Gallotta Giulia, Vacchini Daniela, Tremolada Ylenia, Lazzarin Adriano, Clementi Massimo, Castagna Antonella
Abstract excerpt
To investigate the dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors (NNRTIs), we selected the Human Immunodeficiency Virus (HIV)-infected patients with the mutation at the time or after the failure of an NNRTI-containing regimen from an observational database. Of 62 patients fulfilling the inclusion criteria, 39 continued antiretroviral treatment without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.